Jersey Shore University Medical Center
Clinical research site in Neptune City, New Jersey · 1945 CORLIES AVE, ROUTE 33, NEPTUNE CITY, NJ 07753-4859 · (732) 776-4267
As of September 2026, 35 paid clinical trials are recruiting at Jersey Shore University Medical Center in Neptune City, New Jersey. Active studies at this site cover conditions such as Atrial Fibrillation, ADHF and Alport Syndrome. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Jersey Shore University Medical Center (35)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Pivotal Study for the Cardiac Performance System (CPS)
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
Phagenyx® Registry Study
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
E-Mindfulness Approaches for Living After Breast Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Project: Every Child for Younger Patients With Cancer
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Leveraging the Emergency Department (LEAD) Study
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Get new-trial alerts for Jersey Shore University Medical Center
We'll email you whenever a new clinical trial starts recruiting at this research site in Neptune City, NJ. Unsubscribe anytime.
More research sites in Neptune City
- Jersey Shore Medical Center (16 trials)
- HMH Jersey Shore University Medical Center (3 trials)
- HOPE Tower at Jersey Shore University Medical Center (2 trials)
- Hackensack Meridian Health Jersey Shore University Medical Center (2 trials)
- 287 (1 trial)
- HMH Jersey Shore University Medical Ctr. (1 trial)
- Hackensack Meridian (1 trial)
- Hackensack Meridian Health (1 trial)
- Hackensack Meridian Health - Jersey Shore University Medical Center (1 trial)
- Hackensack Meridian Health Jsumc (1 trial)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Neptune City, NJ · New Jersey clinical trials